Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer

ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstituto Nacional de Cancerologia de Mexico

About this trial

The goal of this non experimental, transversal instrument study is to Construct and determine the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer in Mexican patients with a lung cancer diagnosis.

The main question it aims to answer is: What is the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer of the patients with this diagnosis that are currently undergoing an assessment or follow up program of Respiratory Rehabilitation?

The Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC) will be psychometrically valid and reliable for the evaluation of therapeutic adherence on patients with lung cancer that are undergoing an assessment or follow up of Respiratory Rehabilitation.Participants will be asked to fill out an Identification card and fill out the fifty-six items presented on the STA-RR-LC.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients diagnosed with lung cancer (SCLC and NSCLC).

Over 18 years of age.

Voluntary participation by understanding and accepting the informed consent letter.

Patients undergoing Respiratory Rehabilitation treatment with one month assessment and follow-up.

Disqualifiers

Severe hearing or visual problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the clinical record file).

Severe psychiatric conditions (schizophrenia or psychotic disorders) and/or addiction to any psychoactive substance (this will be identified as reported in the INCanet file).

Attentional or memory problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the INCanet file).

Trial population

Any patient registered in the national cancer center with respiratory rehabilitation follow-up.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer (STA-RR-LC)

    Behavioral

    Patients will be given a measurement instrument to determine the level of therapeutic adherence.

Treatment groups

281 Participants
are divided into 1 treatment group
Group A: Adherence group1 intervention

Trial outcomes

Primary outcomes

1

Contruction of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC)

The validity of the construction is carried out with an exploratory factor analysis using the Maximum Likelihood extraction method and the oblique rotation (direct Oblimin). Confiability is determitated using the Alpha of Cronbach coefficient.

Time frame
the STA-RR-LC will be applied for one time and as soon as the patient has completed one month attending the Respiratory Rehabilitation Service.

Secondary outcomes

1

Verify the concurrent validity of the instrument

It will be verified using the current scores of the European Organisation for Research and Treatment of Cancer, specifically the Module of Lung Cancer (EORTC-QLQ-LC29).

Time frame
the STA-RR-LC will be applied one time, as soon as the patient has completed one month attending the Respiratory Rehabilitation Service

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.